Based in Cambridge, MA, GeneWorx Capital is a technology venture development firm. Our team is comprised of MIT technologists, former WallStreet VC investors and Silicon Valley tech entrepreneurs. Our partners have built several tech companies from prototype to high value exit (M&A/IPO) creating billions of dollars of shareholder value. Our mission is to build high value enterprises from emergent life science companies and innovations. We accelerate commercialization and growth of startups, spinouts from labs and large companies, and businesses within large companies. Securities offered through Finalis Securities LLC Member FINRA/SIPC. GeneWorx Capital LLC and Finalis Securities LLC are separate, unaffiliated entities.